What company bought Horizon?
Horizon Therapeutics plc, a prominent global biotechnology enterprise focused on rare and autoimmune diseases, was acquired by Amgen in a massive cash transaction representing an equity value of approximately $27.8 billion. This major pharmaceutical acquisition added several first-in-class breakthrough medicines—such as Tepezza and Krystexxa—to Amgen's core inflammation and rare disease therapeutic portfolios.
Related FAQs
Determining the financial stability, legitimacy, and regulatory compliance of a life insurance company involves checking state insurance commissioner registries and independent financial rating agencies.
Horizon Bank receives generally positive reviews from retail and commercial customers for delivering accessible checking accounts, competitive mortgage lending options, user-friendly digital banking applications, and responsive local customer serv...
Companies operating under the Horizon name across different industries—such as healthcare distribution, media, or banking—generally maintain solid commercial reputations, substantial market capitalization scales, and professional corporate governa...
Horizon Financial operates as a legitimate mortgage lending and financial services entity holding proper state licensing and regulatory registrations to originate home loans and manage consumer credit services.
Horizon Financial Services operates as a real, registered business entity providing specialized financial solutions, mortgage origination, or investment advisory services depending on its specific regional licensing.
Horizon risk refers to the financial uncertainty or danger that an investor’s planned investment time horizon may be unexpectedly shortened due to unforeseen personal or economic events.